CRISPR News

Learn how long stranded DNA (lssDNA) donor templates facilitates knockin CRISPR/Cas9 editing efficiency for animal model generation.

Learn how CRISPR/Cas9 gene-editing ex vivo and in vivo approaches are progressing to treat beta-thalassemia, sickle cell disease, Leber congenital amaurosis, and hereditary transthyretin amyloidosis.

Novel CRISPR-based Non-viral Approach for CAR T Cell Generation

Overcoming Antibiotic Resistance with CRISPR

Learn about strategies to improve the efficiency of CRISPR mediated knock-in of donor DNA templates.

CRISPR/Cas9 Used to Edit Gene Variance in Human Stem cell-derived β cells from a Patient with Monogenic Diabetes and Reverse Preexisting Diabetes in Mice

Learn about Jennifer Doudna and Emmanuelle Charpentier, the 2020 Nobel prize-Chemistry recipients, for elucidating CRISPR/Cas9’s mechanisms in bacterial immunity as well as its potential for genome editing applications.

Learn about CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)/Cas delivery and how viral vs non-viral approaches compare.

Learn how CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)/Cas system is changing the way infectious diseases such as COVID are diagnosed at the clinic.

Recently, three independent teams published their findings on using CRISPR–Cas9 gene editing to remove genetic defects in human embryos. Despite correct fixation of target gene, large DNA fragment deletion and reshuffling resulted from CRISPR editing is a